Clinical Trial

Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults

by

The Evolution of COVID-19 Treatment: From Broad Application to Precision Care The landscape of antiviral treatment is shifting. For years, the primary goal of early intervention with Paxlovid (nirmatrelvir-ritonavir) was the prevention of severe outcomes, such as hospitalization and death. However, as vaccination rates have climbed, the clinical utility of these treatments is evolving. View … Read more

Eating oranges daily may shift lipid patterns in fatty liver disease

by

Beyond the Plate: The Future of Fighting Fatty Liver with Precision Nutrition For decades, the medical advice for fatty liver disease was simple, if frustrating: “lose weight and eat better.” But as we move deeper into the era of personalized medicine, we are discovering that the fight against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is … Read more

Microbes in the digestive tract help tailor treatment for melanoma patients

by

The New Frontier of Oncology: Can Your Gut Bacteria Predict Cancer’s Return? For decades, the fight against melanoma has relied on a standard playbook: surgical removal followed by immunotherapy to prime the immune system. But for 25% to 40% of patients, the cancer finds a way back. The medical community has long struggled with a … Read more

Prostate cancer patients recover faster with TULSA than robotic surgery

by

Minimally Invasive Prostate Cancer Treatment: A New Era of Faster Recovery? Men diagnosed with localized, intermediate-risk prostate cancer may soon have a new option that prioritizes a quicker return to daily life. A recent randomized clinical trial, presented at the 2026 Society of Interventional Radiology (SIR) Annual Scientific Meeting, suggests that MRI-guided, transurethral ultrasound ablation … Read more

Sylvester Comprehensive Cancer Center opens new trial for neuroendocrine tumors

by

Hope on the Horizon: New Trial Targets Aggressive Neuroendocrine Tumors A new clinical trial at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is offering a beacon of hope for patients battling high-grade neuroendocrine tumors (NETs). These complex and aggressive cancers have historically seen limited medical advancements due to … Read more

Low-cost care model reduces blood pressure in high-risk populations

by

New NIH Study Highlights Promising Approach to Tackle Hypertension in Underserved Communities A recent clinical trial funded by the National Institutes of Health (NIH) reveals a scalable, team-based intervention significantly reduces systolic blood pressure among low-income individuals. The findings, published in the New England Journal of Medicine, offer a beacon of hope in addressing the … Read more

Estradiol patches as effective as injections for locally advanced prostate cancer

by

Prostate Cancer Treatment: Patches Offer Hope for Fewer Side Effects Men diagnosed with locally advanced prostate cancer may soon have a more convenient and potentially less debilitating treatment option. A recent clinical trial led by University College London (UCL) researchers has demonstrated that hormone patches are as effective as traditional injections in controlling the disease, … Read more

Exercise during chemotherapy supports physical and cognitive health

by

Chemo and Fitness: How Exercise is Becoming a Vital Part of Cancer Treatment For decades, rest was the standard prescription for cancer patients undergoing chemotherapy. Now, a growing body of research, spearheaded by experts like Dr. Karen Mustian at the Wilmot Cancer Institute, is flipping that script. A recent study published in JNCCN-Journal of the … Read more

Defining the limits of immunotherapy in early small-cell lung cancer

by

Immunotherapy Plateau? New Data Shifts Focus Back to Radiation in Small Cell Lung Cancer A recent international clinical trial, NRG-LU005, has delivered a nuanced message in the fight against limited-stage small cell lung cancer (LS-SCLC). While the addition of immunotherapy drug atezolizumab to standard chemoradiation didn’t significantly improve overall survival, a surprising trend emerged: twice-daily … Read more

60 Degrees Pharma: tafenoquine cures 3 babesiosis patients

by

Babesiosis Breakthrough: 100% Cure Rate Signals a Novel Era in Tick-Borne Disease Treatment A promising development in the fight against babesiosis, a tick-borne illness, has emerged from 60 Degrees Pharmaceuticals. Recent data reveals a 100% cure rate in a little trial of patients with relapsing babesiosis, particularly those with weakened immune systems. This achievement, announced … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]